德康農牧(02419.HK)2023年收入161.55億元 同比增加7.4%
格隆匯3月25日丨德康農牧(02419.HK)公吿,於2023年,公司的收入為人民幣161.55億元,較2022年增加7.4%,主要是由於生豬板塊的收入增加。公司於2023年錄得生物資產公允價值調整前虧損人民幣12.79億元,而2022年則為生物資產公允價值調整前利潤人民幣6.05億元。主要由於生豬價格於2023年大跌,平均售價較2022年同期下跌19.4%,以及商品雞的平均售價較2022年下跌約10%。每股虧損4.88人民幣元。
鑑於外部面臨多重挑戰,公司堅持提升內部能力,開展嚴格的內部基準對標及實施駐場管理方法,以縮小育種結果的差距。此外,公司戰略性地優化管理團隊及推行鍼對性的激勵措施,發揮一線員工的工作熱情及責任感。此外,公司加大采購的市場調研及原材料分析力度,旨在對公司的飼料作出有效的成本控制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.